HSBC Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.2M | Buy |
970,000
+103,300
| +12% | +$2.75M | 0.01% | 660 |
|
|
2025
Q4 | $21.6M | Buy |
866,700
+351,400
| +68% | +$8.86M | 0.01% | 722 |
|
|
2025
Q3 | $13M | Sell |
515,300
-147,900
| -22% | -$3.65M | 0.01% | 841 |
|
|
2025
Q2 | $16.1M | Sell |
663,200
-246,500
| -27% | -$5.75M | 0.01% | 764 |
|
|
2025
Q1 | $22.8M | Sell |
909,700
-895,600
| -50% | -$23.4M | 0.01% | 675 |
|
|
2024
Q4 | $47.9M | Buy |
1,805,300
+1,483,800
| +462% | +$40.2M | 0.03% | 486 |
|
|
2024
Q3 | $9.3M | Buy |
321,500
+23,500
| +8% | +$686K | 0.01% | 941 |
|
|
2024
Q2 | $8.28M | Buy |
298,000
+130,500
| +78% | +$3.59M | 0.01% | 912 |
|
|
2024
Q1 | $4.65M | Sell |
167,500
-508,600
| -75% | -$14.1M | ﹤0.01% | 1128 |
|
|
2023
Q4 | $19.4M | Buy |
676,100
+118,600
| +21% | +$3.59M | 0.02% | 681 |
|
|
2023
Q3 | $18.4M | Buy |
557,500
+383,900
| +221% | +$13.6M | 0.02% | 652 |
|
|
2023
Q2 | $6.27M | Sell |
173,600
-25,600
| -13% | -$996K | 0.01% | 972 |
|
|
2023
Q1 | $8.04M | Sell |
199,200
-40,200
| -17% | -$1.74M | 0.01% | 935 |
|
|
2022
Q4 | $12.2M | Buy |
239,400
+156,400
| +188% | +$7.5M | 0.01% | 848 |
|
|
2022
Q3 | $3.63M | Sell |
83,000
-49,000
| -37% | -$2.38M | 0.01% | 1307 |
|
|
2022
Q2 | $6.72M | Sell |
132,000
-11,500
| -8% | -$586K | 0.01% | 1067 |
|
|
2022
Q1 | $7.43M | Sell |
143,500
-102,800
| -42% | -$5.33M | 0.01% | 1034 |
|
|
2021
Q4 | $14.7M | Buy |
246,300
+20,800
| +9% | +$1.03M | 0.01% | 787 |
|
|
2021
Q3 | $9.82M | Sell |
225,500
-55,000
| -20% | -$2.44M | 0.01% | 889 |
|
|
2021
Q2 | $11.1M | Sell |
280,500
-126,400
| -31% | -$4.92M | 0.01% | 820 |
|
|
2021
Q1 | $14.7M | Buy |
406,900
+93,200
| +30% | +$3.31M | 0.02% | 691 |
|
|
2020
Q4 | $12.1M | Buy |
313,700
+264,267
| +535% | +$9.69M | 0.02% | 736 |
|
|
2020
Q3 | $1.72M | Buy |
49,433
+39,947
| +421% | +$1.4M | ﹤0.01% | 1327 |
|
|
2020
Q2 | $294K | Buy |
+9,486
| New | +$322K | ﹤0.01% | 2140 |
|
|
2019
Q4 | – | Sell |
-265,503
| Closed | -$9.05M | – | 3154 |
|
|
2019
Q3 | $9.05M | Sell |
265,503
-289,428
| -52% | -$10.5M | 0.02% | 898 |
|
|
2019
Q2 | $22.8M | Buy |
554,931
+355,514
| +178% | +$14.1M | 0.04% | 441 |
|
|
2019
Q1 | $8.04M | Sell |
199,417
-431,402
| -68% | -$17.3M | 0.01% | 912 |
|
|
2018
Q4 | $26.1M | Buy |
630,819
+294,382
| +87% | +$12.2M | 0.05% | 402 |
|
|
2018
Q3 | $14.1M | Buy |
336,437
+174,016
| +107% | +$6.7M | 0.02% | 701 |
|
|
2018
Q2 | $5.59M | Sell |
162,421
-5,270
| -3% | -$180K | 0.01% | 1072 |
|
|
2018
Q1 | $5.64M | Buy |
167,691
+127,639
| +319% | +$4.39M | 0.01% | 1066 |
|
|
2017
Q4 | $1.38M | Sell |
40,052
-526,789
| -93% | -$18M | ﹤0.01% | 1209 |
|
|
2017
Q3 | $19.2M | Sell |
566,841
-492,851
| -47% | -$15.8M | 0.03% | 563 |
|
|
2017
Q2 | $33.8M | Sell |
1,059,692
-214,172
| -17% | -$6.75M | 0.06% | 322 |
|
|
2017
Q1 | $41.4M | Sell |
1,273,864
-66,929
| -5% | -$2.11M | 0.09% | 225 |
|
|
2016
Q4 | $41.3M | Buy |
1,340,793
+567,262
| +73% | +$17.3M | 0.1% | 230 |
|
|
2016
Q3 | $24.9M | Buy |
773,531
+417,068
| +117% | +$13.9M | 0.06% | 352 |
|
|
2016
Q2 | $11.9M | Buy |
356,463
+286,899
| +412% | +$9.16M | 0.03% | 601 |
|
|
2016
Q1 | $1.96M | Sell |
69,564
-184,134
| -73% | -$5.26M | 0.01% | 1153 |
|
|
2015
Q4 | $7.8M | Buy |
253,698
+185,188
| +270% | +$5.83M | 0.02% | 780 |
|
|
2015
Q3 | $2.04M | Buy |
68,510
+67,983
| +12,900% | +$2.18M | 0.01% | 1060 |
|
|
2015
Q2 | $17K | Sell |
527
-108,140
| -100% | -$3.52M | ﹤0.01% | 2020 |
|
|
2015
Q1 | $3.61M | Sell |
108,667
-89,169
| -45% | -$2.83M | 0.01% | 1019 |
|
|
2014
Q4 | $5.85M | Buy |
197,836
+10,540
| +6% | +$302K | 0.01% | 851 |
|
|
2014
Q3 | $5.26M | Buy |
187,296
+34,361
| +22% | +$964K | 0.01% | 854 |
|
|
2014
Q2 | $4.31M | Buy |
152,935
+102,659
| +204% | +$2.93M | 0.01% | 889 |
|
|
2014
Q1 | $1.53M | Sell |
50,276
-380,494
| -88% | -$11.3M | ﹤0.01% | 1135 |
|
|
2013
Q4 | $12.5M | Buy |
430,770
+94,860
| +28% | +$2.76M | 0.03% | 547 |
|
|
2013
Q3 | $9.15M | Buy |
+335,910
| New | +$9.14M | 0.03% | 634 |
|
Other funds holding PFE
VCM
VPM
HSBC Holdings's PFE Position: Q1 2026 in Review
HSBC Holdings reduced its Pfizer (PFE) stake by 7.3% in Q1 2026, selling an estimated $31M and leaving 14,769,053 shares worth $414M. The position accounts for 0.22% of the portfolio, ranked #85.
HSBC Holdings first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $575M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- HSBC Holdings held 14,769,053 shares of Pfizer worth $414M as of Q1 2026.
- HSBC Holdings sold 1,165,180 Pfizer shares in Q1 2026, an estimated $31M.
- Pfizer made up 0.22% of HSBC Holdings's portfolio in Q1 2026, its #85 holding.
- HSBC Holdings first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Pfizer position peaked at $575M in Q4 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.